http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_545e4bf9e55ddfd40602596ad41adf06
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Scita |
| name | Giorgio Scita |
| given-name | Giorgio |
| organization-name | ‡Italian Foundation for Cancer Research Institute for Molecular Oncology, Milan 20139, Italy; and; §Department of Oncology and Hemato-Oncology, Italian Database of Operational Losses, University of Milan, Milan 20142, Italy European Institute of Oncology, The FIRC Institute for Molecular Oncology, 20139 Milano, Italy; IFOM, the FIRC Institute of Molecular Oncology Foundation, 20139 Milan, Italy FIRC (Fondazione Italiana per la Ricerca sul Cancro) Institute of Molecular Oncology (IFOM), Milan 20139, Italy 3; Department of Oncology and Hemato-Oncology, School of Medicine, University of Milan, Milan 20122, Italy 4 European Institute of Oncology (IEO) and The FIRC Institute for Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy Authors' Affiliations: 1Institut National de la Santé et de la Recherche Médicale (INSERM), U1043, Centre de Physiopathologie de Toulouse Purpan; 2INSERM, U1048; 3INSERM, U1037, Centre de Recherche en Cancérologie de Toulouse; 4Centre National de la Recherche Scientifique (CNRS), U5282; 5Université Toulouse III Paul-Sabatier; 6Department of Hematology, Purpan University Hospital, Toulouse, France; 7IFOM (FIRC Institute for Molecular Oncology); and 8Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy; Authors' Affiliations: 1Institut National de la Santé et de la Recherche Médicale (INSERM), U1043, Centre de Physiopathologie de Toulouse Purpan; 2INSERM, U1048; 3INSERM, U1037, Centre de Recherche en Cancérologie de Toulouse; 4Centre National de la Recherche Scientifique (CNRS), U5282; 5Université Toulouse III Paul-Sabatier; 6Department of Hematology, Purpan University Hospital, Toulouse, France; 7IFOM (FIRC Institute for Molecular Oncology); and 8Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy The European Institute of Oncology (IEO) and the FIRC Institute for Molecular Oncology (IFOM), Via Adamello 16, 20139 Milan, Italy IFOM Istituto FIRC di Oncologia Molecolare Via Adamello 16, 20139, Milan, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Via Ripamonti 435, 20141, Milan, Italy IFOM FOM Foundation Institute FIRC of Molecular Oncology and University of Milan, School of Medicine, Department of Oncology and Hemato‐Oncology‐DIPO, Via Adamello Milan Italy 2Fondazione Italiana per la Ricerca sul Cancro Istituto di Oncologia Molecolare, 20139 Milan, Italy; 3Department of Experimental Oncology, Istituto Europeo di Oncologia, 20141 Milan, Italy IFOM; Fondazione Istituto FIRC di Oncologia Molecolare; Milan, Italy; Dipartimento di Scienze della Salute; Universita di Milano; Milan, Italy *IFOM, the FIRC Institute of Molecular Oncology Foundation, 20139 Milan, Italy;; European Institute of Oncology, 20141 Milan, Italy;; University of Milan, 20122 Milan, Italy Dipartimento di Scienze della Salute, San Paolo, University of Milan, 20122 Milan, Italy; The FIRC Institute for Molecular Oncology, 20134 Milan, Italy; Department of Experimental Oncology, Istituto Europeo di Oncologia, 20141 Milan, Italy 1Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy Authors' Affiliations: 1Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany; 2IFOM Foundation, Institute FIRC of Molecular Oncology and University of Milan, Milan, Italy; 3Department of Pharmacy, Pharmaceutical Biotechnology, University of Munich, Munich, Germany; 4Department of Chemistry, University of Munich, Munich, Germany; 5Department of Biophysics and Cell Biology, University of Debrecen, Debrecen, Hungary; 6Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Department of Pharmaceutical Biotechnology, Saarland University, Saarbrücken, Germany IFOM‐FIRC Institute of Molecular Oncology,Department of Oncology and Hemato‐Oncology,University of Milan,Milan,Italy,Milan,Italy IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy FIRC Institute of Molecular Oncology, 20139 Milan, Italy 1; Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy 5 From the Units of General Surgery 2, Immunotherapy of Human Tumors, Immunohematology and Blood Bank, Pathology, Diagnostic Radiology, and Pharmacy, Istituto Nazionale Tumori; Divisions of Surgery and Pathology, Istituto Europeo di Oncologia, Milan; Units of Cancer Biotherapy, Anesthesiology, and Surgery, Centro di Riferimento Oncologico, Aviano; Divisions of Medical Oncology and Surgery, Istituto Scientifico Tumori, Genoa; and Sigma Tau, i.f.r. S.p.A., Rome, Italy; Antigenics, Inc, Woburn, MA; and Center... IFOM, Fondazione Istituto FIRC di Oncologia Molecolare; Dipartimento di Medicina, Chirurgia ed Odontoiatria, Universita' degli Studi di Milano; and Istituto Europeo di Oncologia, Milan, Italy IFOM‐FIRC Institute of Molecular Oncology Via Adamello, 16 Milan 20139 Italy; Department of Oncology and Haemato‐Oncology Università degli Studi di Milano Via Festa del Perdono, 7 Milan 20122 Italy 1Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy IFOM-FIRC Institute of Molecular Oncology; Milano; Italy; Università degli Studi di Milano; Dipartimento di Oncologia e Emato-Oncologia IFOM Foundation, Institute FIRC of Molecular Oncology, University of Milan,School of Medicine, Dpt. San Paolo, Via Adamello, 16 20139 Milano,Italy. Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), 20139 Milan, Italy 1; Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20122 Milan, Italy 3 3Instituto Fondazione Italiana Ricerca sul Cancro di Oncologia Molecolare, 20139 Milan, Italy |
Incoming Links
Total number of triples: 135.